Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

@article{Sandler2006PaclitaxelcarboplatinAO,
  title={Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.},
  author={Alan Sandler and Robert Gray and Michael C. Perry and Julie R. Brahmer and Joan H. Schiller and Afshin Dowlati and Rogerio C Lilenbaum and Diana H Johnson},
  journal={The New England journal of medicine},
  year={2006},
  volume={355 24},
  pages={
          2542-50
        }
}
BACKGROUND Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to benefit patients with a variety of cancers. METHODS Between July 2001 and April 2004, the Eastern Cooperative Oncology Group (ECOG) conducted a randomized study in which 878 patients with recurrent or advanced non-small-cell lung cancer (stage IIIB or IV) were assigned to chemotherapy with paclitaxel and carboplatin alone (444) or paclitaxel and carboplatin plus bevacizumab (434… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 2,978 CITATIONS, ESTIMATED 50% COVERAGE

Assessing the clinical outcome of nab‐paclitaxel in Chinese patients with advanced non‐small‐cell lung cancer

  • The clinical respiratory journal
  • 2017
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Lung cancer in Fujian Province , China ( 2009-2012 ) : a single-institute retrospective study

Hongru Li, Yanling Wu, +11 authors Yusheng Chen
  • 2016
VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancer.

  • Translational lung cancer research
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumab

  • Investigational New Drugs
  • 2015
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2006
2020

CITATION STATISTICS

  • 236 Highly Influenced Citations

  • Averaged 168 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

ture with anti - angiogenic therapy : a new paradigm for combination therapy

RK Jain
  • Nat Med
  • 2001